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Within-host evolution has resulted in thousands of variants of Salmonella that
exhibit remarkable diversity in host range and disease outcome, from broad
host range to exquisite host restriction, causing gastroenteritis to disseminated
disease such as typhoid fever. Within-host evolution is a continuing process
driven by genomic variation that occurs during each infection, potentiating
adaptation to a new niche resulting from changes in animal husbandry, the use
of antimicrobials, and emergence of immune compromised populations. We
discuss key advances in our understanding of the evolution of Salmonella
within the host, inferred from (i) the process of host adaptation of Salmonella
pathovars in the past, and (ii) direct observation of the generation of variation
and selection of beneﬁcial traits during single infections.
The Signiﬁcance of Within-Host Evolution
During infection in its many mammalian, avian, amphibian, and reptile hosts, Salmonella is in
constant competition with other microorganisms for a niche that provides nutrients for repli-
cation, and must contend with the host immune defences that limit or prevent spread beyond
the intestinal mucosa. Salmonella coevolved with animal hosts for millions of years since
diverging from a common ancestor with Escherichia coli (Box 1), and it is likely that most
mutations that arise during infection are either neutral or detrimental, and therefore either ﬁxed
at low frequency by genetic drift (see Glossary) or rapidly lost (Figure 1). This is illustrated by
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Box 1. Evolution of Salmonella Pathogenesis
The genus Salmonella comprises over 2500 serovars in two species, S. bongori and S. enterica; the latter contains
subspecies I, II, IIIa, IIIb, IV, VI, and VII. All Salmonella serovars cause disease essentially by the same mechanisms, because
soon after divergence from a common ancestor, Salmonella acquired key virulence genes. These include two type III
secretion systems(T3SS-1andT3SS-2)encodedonSalmonellapathogenicity islands 1 and2 (SPI-1andSPI-2) that enable
invasion ofhost epithelium andsubsequent intracellular survival [88,89]. T3SSsare supramolecular structures, resembling a
syringe, that translocate effector proteins across host cell membranes. Initially, Salmonella coevolved with cold-blooded
host species, with subspecies I in particular expanding its host range to include warm-blooded animals, the major zoonotic
reservoir for human infection. Serovars of subspecies I consequently account for the vast majority of human infections.
Evolution of subspecies I within these hosts included the acquisition of around 216 genes [90], including shdA involved in
persistent intestinal colonisation [56]. Salmonella primarily evolved as a gastrointestinal pathogen, with infection limited to
the intestinal lumen, intestinal mucosa, and associated lymphoid tissue. Invasion of the intestinal mucosa is a strategy to
generate an intestinal niche in the lumen that favours the replication of Salmonella over the intestinal microbiota. Invasion
elicits a host inﬂammatory response [5], exploiting host-derived metabolites and resisting antimicrobial defences speciﬁc to
the inﬂamed intestine [91]. Gastroenteritis isacute and self-limiting; nonetheless, theshort-termproliferation of Salmonella in
the intestine ensures transmission. However, in some Salmonella serovars, within-host evolution has resulted in adaptation
to an alternative transmission lifestyle that does not rely on replication in the intestine, but rather, dissemination to systemic
sites, niches devoid of competing microbiota allowing persistence that can last the lifetime of the host. Within-host evolution
on multiple occasions resulted in a number of host-adapted serovars (pathovars) often with apparent convergence in
pathogenesis, in the same or distinct host species, and reﬂected in the convergence of their genome sequence [92–94]. For
example, S. Typhi and S. Paratyphi A cause typhoid and paratyphoid, similar diseases restricted to humans; S. Gallinarum is
associated with a disease called fowl typhoid; S. Abortus-ovis is associated with abortion in sheep, due to a tropism for the
placenta; and S. Dublin and S. Choleraesuis are associated with bacteraemia in cattle and pigs, respectively. In each case,
within-host evolution has selected for variants that evade detection by the host innate immune system, with concomitant
blunting of the inﬂammatory response in the intestinal mucosa that facilitates dissemination to systemic sites.
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Glossary
Disseminated disease: infections
that progress beyond the intestinal
mucosa and associated lymphoid
tissue.
Diversifying selection: change in
frequency of a mutation due to its
beneﬁcial effect on the ﬁtness of the
organism.
DT: deﬁnitive type (phage type).
Genetic drift: changes in the
frequency of mutations that are not
under selection.
Hypermutator: a phenotype in
which the normal substitution rate of
an organism is elevated.
Lysogeny: the integration of
bacteriophage DNA into the bacterial
chromosome.
Phage: a virus particle that replicates
within bacteria.
Phage type: a typing scheme based
on the sensitivity of strains to lytic
phage.
Phase variation: an heritable
expression state of a protein
frequently in an ON–OFF fashion.
Purifying selection: changes in the
frequency of mutations due to their
detrimental effect on the ﬁtness of
the organism.
Recrudescence: a recurring
infection due to the same strain of
pathogen that asymptomatically
persists in the host.
Serovar: a variant of Salmonella
based on intergenic variation of
surface structures.
Temperate phage: a phage that is
able to integrate into the bacterial
genome and reside as a prophage.
Typhoid fever: disseminated
disease caused by the host-
restricted pathogen Salmonella
Typhi.the scarcity of nonsynonymous compared to synonymous substitutions (dN/dS <1) during
short-term evolution of Salmonella [1], signifying that nonsynonymous single-nucleotide poly-
morphisms (SNPs) are subject to purifying selection. However, evolution of Salmonella may
occur when a mutation provides an advantage in a novel niche in which to replicate, and if this
also provides an opportunity to transmit to a subsequent host, it may be a stable event. Novel
niches take many forms, including nutrient availability, the presence of antimicrobial, alternative
tissue or organ sites in the same host, such as with disseminated infections, alternative hosts
with altered immune status, or an alternative host species. Regardless of its nature, entry into a
new niche alters natural selection on sequence variation arising from replication errors and
horizontal gene transfer (HGT), resulting in an increase in the frequency of beneﬁcial mutations,
termed diversifying selection (Box 2). Observations of within-host evolution of Salmonella that
led to the emergence of distinct pathovars and disseminated disease, indicate that this is
normally associated with a decrease in host range, because mutations beneﬁtting replication in
systemic sites in one host species do not result in the same beneﬁt in other host species. This
creates an apparent paradox whereby a decrease in the population size of susceptible hosts
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Figure 1. Within-Host Evolution of
Salmonella and Its Consequences.
Illustration of Salmonella (white circle)
entering a host animal (blue or green out-
line) resulting in the emergence of varia-
tion during replication (colour-ﬁlled
circles). Variants with beneﬁcial traits
increase in frequency due to diversifying
selection (red and purple circles), while
those with detrimental or neutral traits
are lost from the population by genetic
drift or purifying selection (marked ‘X’).
However, within-host evolution, resulting
in the increased frequency of beneﬁcial
mutations, may not be beneﬁcial outside
of the host and counter-selected due to
its loss in ﬁtness for transmission (red
circle with ‘X’) or result in increased ﬁtness
(purple circle) in one host (blue outline) but
decreased ﬁtness (purple circle marked
with ‘X’) in a second host species (green
outline), in which case host restriction
may occur.
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accompanies host adaptation, a seemingly evolutionary unstable event. In practice, there is a
trade-off for the relative beneﬁt to transmission in a single host species population, and the
decrease in host range due to loss of ﬁtness in other hosts [2]. In the case of Salmonella enterica
serovar Typhi (S. Typhi), host restriction to humans was accompanied by a distinct transmis-
sion strategy involving dissemination to systemic sites to gain access to the gall bladder,
establishing long-term persistence. The decrease in number of susceptible hosts due to host
restriction was counterbalanced by the increased longevity of transmission.
Within-host evolution is also constrained by the need for Salmonella to survive in the environ-
ment and to be transmitted to subsequent hosts. Consequently, if a mutation results in greater
replication within the host, but confers a ﬁtness cost in the environment or for colonisation of a
subsequent host, the variant will not be viable (Box 2). An elegant example are variants with
mutations leading to the loss of expression of energetically expensive virulence genes such as
the type III secretion system-1 (T3SS-1, Box 1), required for invasion of host cells. These
variants replicate more rapidly than those expressing T3SS-1 in vitro and in vivo [3]. Invasion of
the intestinal mucosa by the Salmonella population expressing the T3SS-1 is an example of
self-destructive cooperation [4], because bacteria that invade and elicit inﬂammation do not
beneﬁt from the resulting inﬂamed intestinal niche [5–7]. This is open to exploitation by faster
replicating variants that do not express T3SS-1, and indeed irreversible loss of expression of
T3SS-1 is observed at a surprisingly high frequency during infection due to mutation of HilD, the
master-regulator of T3SS-1 [3]. The evolutionary instability of invasion appears to be counter-
acted by phase variable expression of the T3SS-1. That is, only a proportion of Salmonella
enterica serovar Typhimurium (S. Typhimurium) in the population express the T3SS-1, the
remainder compete with the hilD mutant variants in the lumen, yet are capable of switching
back to the T3SS-1 phase ON mode in subsequent hosts [3]. While phase variation of other
supramolecular structures such long polar ﬁmbriae (LPF) has been proposed to contribute to
maintaining the ability to infect a broad host range and evade cross immunity [8], phase
variation of LPF that contribute to colonisation of lymphoid tissue of the intestinal mucosa [9]
may also counter self-destructive cooperation. Phase variation of lpf varies depending on
Box 2. Sources of Variation and Selection of Traits within the Host
Genome sequence variation results from point mutations, horizontal gene transfer (HGT), deletions, duplications and
rearrangements. Point mutations arise at a rate of around 1  109 to 1  1010 per base pair per generation [95], and
although extremely low, the large overall population size during infection, and the short generation time, provides the
opportunity for diversity to arise during a single infection. Although the HGT rate is comparable to point mutation, HGT
dominates prokaryotic evolution because the impact on heritable traits is greater due to the introduction of new
functional genes [96,97]. The dominance of HGT on Salmonella evolution is apparent from the observation that S. Typhi
and S. Typhimurium share an average nucleotide identity of around 99%, yet around 15% of their genes are serovar-
speciﬁc [13,14]. Genes affected include prophage, pathogenicity islands, ICEs, transposons, IS elements, and plasmids
[90]. Despite the clear importance of HGT in the evolution of Salmonella, especially over longer time scales since
serovars shared a common ancestor, the emergence of new pathovars over short time scales can occur with little or no
HGT [38]. In these cases, point mutations in a genome sequence appear more important, although their impact on
function is difﬁcult to predict. Insight into the functional divergence of proteins using a proﬁle-based method with hidden
Markov models is a promising approach [98]. Mutations in transcriptional regulators and regulatory sequences have the
potential to have a broad ranging impact on traits of the organism. Indeed, pathovars of Salmonella have diverse
regulatory networks, and are also likely to play an important role in the evolution of Salmonella [32]. For example, the
PhoP regulon, which includes 3% of the S. Typhimurium genome, is known to be highly plastic, with transcriptional
rewiring affecting gain and loss of interactions with shared sets of genes in members of the Enterobacteriaceae [99].
Regardless of the mechanism, variation that is unfavourable is rapidly lost from the population by purifying selection,
while beneﬁcial mutations increase in frequency by the process of diversifying selection. Neutral mutations are
normally ﬁxed in the population at low frequency, because of the large effective population size of bacterial species.
However, during infection, the population goes through bottlenecks, potentially resulting in increased frequency of
neutral mutations [100,101].
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culture conditions, with the phase ON to OFF frequency dominant during replication in the
intestine, providing a phase OFF population in the lumen that can compete with lpf mutants
[10].
The emergence of variation and within-host evolution during infection is therefore a double-
edged sword. It provides a pool of both genotypic and phenotypic diversity capable of
exploiting a new niche and averting extinction – for example, in the face of a sudden insult
from antimicrobials by acquisition of resistance genes, but that is also capable of leading the
pathogen down an evolutionary dead end in the pursuit of short-term advantage. Furthermore,
evolution resulting in a sophisticated level of adaptation to a new host requires multiple
independent adaptations that act in concert and are therefore unlikely to emerge during a
single infection [11]. The source-sink model of pathogen evolution explains how this may occur
from multiple rounds of selection as the pathogen cycles through occupation of source
habitats, where the population is self-sustaining, and sink habitats where the population
can only be maintained by continuous reintroduction from the source habitat [12]. The
source-sink model can explain how multiple rounds of selection for beneﬁcial mutations for
colonisation of an alternative host may occur and eventually result in an exquisitely host-
adapted pathogen that can then be self-sustained and genetically isolated from the ancestral
pathogen variant.
Within-Host Evolution Inferred from Host Adaptation of Salmonella
Pathovars
The evolution of host-adapted variants of Salmonella from broad host range ancestors
occurred on multiple occasions, typically by adaptation to a disseminated disease lifestyle.
Comparative genomics of a broad host range serovar (e.g., S. Typhimurium) with a host-
adapted serovar (e.g., S. Typhi) identiﬁed changes in genome sequence that occurred since
divergence in pathogenic lifestyle [13,14]. This included point mutations impacting protein
sequence, promoters, and regulatory sequences, genome rearrangement, deletions, and
insertions.
The S. Typhi Paradigm
S. Typhi has 601 genes for which there are no orthologues in S. Typhimurium [14]. The
acquisition of two clusters of genes in particular had a profound impact on the evolution of
S. Typhi: a large integrative conjugative element (ICE) called Salmonella pathogenicity island 7
(SPI-7) [15], and three genes encoding a novel A2B5 toxin (Figure 2) [16]. SPI-7 encodes a
number of genes, in the viaB locus, that mediate evasion of detection by the host innate
immune system by either concealing or tightly regulating the expression of conserved molecular
patterns of bacteria recognised by the immune system. The viaB locus encodes the Vi
exopolysaccharide capsule that prevents complement activation by inhibiting binding of natural
IgM to cell-surface macromolecules [17–19]. SPI-7 also encodes a regulator, TviA, that not only
controls biosynthesis of Vi [20] but also regulates expression of ﬂagella and T3SS-1 [21]; after
acquisition, TviA became integrated into the RcsB response regulatory pathway as an auxiliary
protein. Downregulation of ﬂagella and T3SS-1 expression after invasion of the intestinal
mucosa by S. Typhi blunts the immune response in two ways. S. Typhi prevents detection
of ﬂagellin by TLR-5 that activates NF-kB signalling, and Naip5-Naip6/NlrC4/Caspase-1
inﬂammasome complex that activates cytokines interleukin 1b and interleukin-18-mediated
inﬂammatory signalling pathways [21–23], thereby preventing detection of processes induced
by T3SS-1 [24]. Artiﬁcial introduction of the viaB locus into S. Typhimurium results in decreased
immune cell trafﬁcking, decreased proinﬂammatory cytokines, and increased expression of the
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Figure 2. Within-Host Evolution Inferred from Salmonella Typhi Host Adaptation. Broad host range serovar S. Typhimurium and host-restricted serovar S.
Typhi initiate infection by invasion of the intestinal mucosa mediated by T3SS-1-dependent invasion of the epithelium. The expression of ﬂagella and lipopolysaccharide
(LPS) with very long O-antigen chains by S. Typhimurium and the concomitant transfer of effector proteins by the T3SS-1, induces an acute host inﬂammatory response
that prevents dissemination of S. Typhimurium to extraintestinal sites. Key to limiting S. Typhimurium dissemination is the recruitment of neutrophils by both
complement-dependent and -independent mechanisms – where complement activation occurs through the complement component 3 (C3) cleavage product, C3b,
covalently interacting with the exposed O-antigen chains [17,104]. S. Typhi, on the other hand, evades detection by the host immune response to facilitate
dissemination. Through the action of the acquired TviA regulator (encoded by tviA), S. Typhi downregulates the expression of ﬂagella and T3SS-1 while activating
the expression of genes (black arrows) encoding Vi exopolysaccharide (viaB locus) [105–107]. To potentially accommodate the Vi capsule, S. Typhi no longer produces
LPS with very long O-antigen chains, due to disruption (orange ‘X’) of fepE encoding a regulator of O-antigen chain lengths. These changes in gene expression and
coding capacity work together to reduce the host immune response by inhibiting complement activation (C3) and reducing proinﬂammatory cytokine production. For
pathogenesis in the human host, S. Typhi produces the typhoid toxin (red stars) upon internalization via expression of the acquired and subsequently adapted cdtB,
pltA, and pltB genes.
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anti-inﬂammatory cytokines in experimental infections of mice, demonstrating the potential
impact of a single HGT event to within-host evolution [25].
In a seemingly complex series of HGTs and subsequent mutations, S. Typhi acquired and
evolved a novel A2B5 exotoxin [26,27]. The A subunit that exerts the toxic activity associated
with the many symptoms of typhoid exhibits homology to CdtB, a cytolethal distending toxin
present in the genomes of Campylobacter and some E. coli strains, suggesting that interactions
in the intestine with other gut pathogens may have been the source of HGT [26]. The second A
subunit, PltA, and the B subunit PltB, have extensive sequence homology with ArtA and ArtB,
proteins from an A1B5 toxin present in a number of broad host range Salmonella enterica
serovars, implicating a second acquisition during coinfection in the intestine. The unique A2
component of the toxin is made possible by an additional cysteine residue in the C terminus of
PltA, which is not present in ArtA. The PltB subunit directs speciﬁc targeting of the toxin in the
human host, as it binds sialylated glycans present in the human host, but lacks an additional
glycan-binding site present in ArtB that broadens its binding to include glycans present in a
wide range of mammalian hosts [28,29]. Speciﬁc targeting appears important to disease since
a chimeric ArtB/PltA/CdtB toxin had reduced toxicity.
Deletions and point mutations also contributed to the evolution of S. Typhi by impacting
genome degradation. Loss of function mutations may be either a result of reductive evolution, in
which functions are no longer required for a new mode of pathogenesis, or adaptive evolution in
which expression of a gene is detrimental, for example antivirulence genes [30]. S. Typhi lost
nearly 5% (209 genes) of its original coding capacity during the process of adaptation to the
human host and loss of virulence for alternative hosts [14]. Genome degradation impacted
many functions, including genes involved in anaerobic metabolism [31,32] required for out-
growth of Salmonella in the inﬂamed intestine during gastroenteritis [33]. Since inﬂammation in
the intestine is not a common pathology in typhoid fever, the energy expense of expressing
these genes led to reductive evolution. On the other hand, adaptive evolution resulted in
disruption of the fepE gene that prevented expression of very long O-antigen chains of the cell
envelope lipopolysaccharide that would otherwise interfere with deployment of the Vi polysac-
charide capsule [34], and deletion of the ydiQRSTD operon that cooperates with Vi expression
to moderate inﬂammation by preventing butyrate utilization [35].
Recent Host Adaptation of S. Typhimurium Pathovariants
Emergence of host-adapted pathovariants of S. Typhimurium highlights that within-host
evolution and adaptation to new hosts is an ongoing process. They share a common ancestor
in the recent past, differ by around 500–1000 SNPs in the core genome, and exhibit limited
gene ﬂux outside of mobile genetic elements such as phage, ICEs, and plasmids [36–38].
Therefore, in contrast to host-adapted serovars of Salmonella, pathovariants of S. Typhimurium
evolved in the absence of acquisition of pathogenicity islands. For example, the phage type
DT2 pathovariants, which are host restricted to pigeon and cause a typhoid-like disease, have
an almost identical gene complement to broad host range variants of S. Typhimurium [38].
Perhaps the most signiﬁcant adaptation of S. Typhimurium DT2 is a remarkable rewiring of its
transcriptome that results in changes in gene expression in response to elevated temperature,
typical of the avian host, including downregulation of ﬂagella and motility genes, similar to that
observed in S. Typhi [38,39]. Unlike in S. Typhi, where this is achieved by acquisition of the TviA
regulator, no additional regulators are present in DT2, suggesting that convergent evolution is
mediated by point mutations in pre-existing regulatory elements. A second example of the
emergence of a pathovariant is S. Typhimurium ST313, associated with severe disseminated
disease in sub-Saharan Africa [40]. Considerable genome degradation in these strains included
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genes involved in enteropathogenesis, reﬂecting the lack of intestinal involvement in these
infections [41], multicellular behaviour implicated in environmental survival [42,43], serum
sensitivity [44], and dissemination [45]. Evolution of ST313 therefore involved selection for a
variant that hyperdisseminates and has reduced enteropathogenesis [41,46,47].
Direct Observations of Salmonella Within-Host Evolution
Catching evolution in action during natural infections is challenging as selection of variants with
distinct heritable traits typically takes long periods of time, and traits often emerge by
incremental steps that are difﬁcult to measure. Nonetheless, within-host evolution can be
observed when selection is strong, and results in a measurable phenotype such as drug
resistance, or where chronic or recurring infections span relatively long periods, especially if this
is accompanied by hypermutation [48]. Within-host evolution can also be observed in experi-
mental infections, where strong selection pressure can be applied in a controlled manner and
speciﬁc evolutionary events monitored [49].
Within–Host Evolution in Clinical Infections
Although nontyphoid Salmonella infections are commonly acute and self-limiting, a
meta-analysis of surveillance data in Israel found that around 2% of cases resulted in persistent
infection, often associated with the inappropriate use of antibiotics [50]. Recurrence is
considerably higher in disseminated disease caused by nontyphoid Salmonella (also called
invasive NTS, iNTS disease) in HIV-infected adults, where recurrence is as high as 25% [51].
Whole-genome sequencing of pairs of strains from persistent clinical infections identiﬁed more
sequence variation than would be expected based on molecular clock rates estimated from
Salmonella epidemics or outbreaks [1,52–54]. The reason for the higher rate in the host is not
known but may reﬂect either an innately higher mutation rate in vivo or reﬂect a higher replication
rate in the host compared to in the environment during transmission between hosts. A large
number of SNPs resulted in changes in coding sequence of proteins, including some involved in
transcriptional regulation and virulence, that in some cases resulted in altered pathogenicity,
consistent with adaptation [50,54]. Furthermore, a strain that persisted for several weeks in a
patient contained ten SNPs in the shdA gene that encodes a surface localized ﬁbronectin-
binding protein involved in intestinal persistence [55,56]. Persistence for relatively short periods
of time, 1–3 months, was also associated with HGT in the form of changes in prophage
and plasmids [50,57]. In a well documented case of disseminated disease caused by
S. Typhiumuirum ST313 in Malawi, a strain from a recrudescent infection, that had an identical
genome sequence to the strain initially isolated, had acquired an IncHI2 plasmid conferring
resistance to ceftriaxone [57]. Third-generation cephalosporins such as ceftriaxone had
become a key antibiotic in treatment since the widespread emergence of the multidrug-
resistant (MDR) S. Typhimurium ST313 epidemic clone. This was the ﬁrst recorded case of
an MDR S. Typhimurium ST313 strain expressing extended-spectrum b-lactamase (ESBL).
The site of recrudescence in the patient was not known, although iNTS infection is generally
disseminated, with Salmonella isolation from the blood and bone marrow being the most
common [40]. The opportunity for variation arising from HGT would therefore appear to be
limited, and ESBL-expressing Salmonella were exceedingly rare in the region. However, enteric
bacteria expressing ESBL were relatively common, appearing soon after the ﬁrst use of
ceftriaxone for the general treatment of sepsis, some years previously [58]. It is therefore
plausible that treatment of this patient with ceftriaxone partially decolonised the intestine,
providing a niche colonised by an enteric bacterium containing the IncHI2 plasmid, that was
transferred to the recrudescent S. Typhimurium strain. Persistent infections are more common
in typhoid fever, but the whole-genome sequence of sequential isolates has not been deter-
mined to date. However, genomic rearrangements due to recombination between rRNA genes
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has been reported in sequential isolates from typhoid carriers, but was not observed during
culture in vitro, suggesting a role in adaption to long-term carriage [59].
The potential of whole-genome sequencing to inform future clinical management of compli-
cated infections, or even proactive management during an ongoing infection, is apparent from
two well documented cases [60,61]. In the ﬁrst, a patient with IL-12/23 b1 receptor deﬁciency
was found to have a chronic persistent bacteraemia spanning over 15 years, due to a single
infecting clone [61] (Box 3). The S. Enteritidis infection appeared to rapidly adapt to a systemic
infection lifestyle in the immune compromised patient, resulting in increasingly occult bacter-
aemia. Despite the clonal nature of the infecting S. Enteritidis, sequential isolates over a 10-year
period exhibited considerably greater genome sequence diversity than was expected, due to a
hypermutator phenotype. Although recurrent infections with Salmonella are not uncommon in
immunocompromised patients, they are normally resolved by antibiotic treatment. Yet in this
case, repeated antimicrobial therapy resulted in the rapid emergence of resistance, suggesting
that hypermutation was linked to the treatment failure, and suggested that alternative clinical
management was appropriate. In a second documented case, the whole-genome sequence of
a series of S. Typhimurium strains isolated over a 5-month period from a patient with a chronic
infection for which antibiotic treatment ultimately failed, led to insight into the mechanism of
treatment failure and contributed to the mechanistic understanding of drug resistance [62,63].
Importantly, pre- and post-therapy isolates were investigated, and the last isolate was found to
contain a novel substitution in the AcrB protein, a component of a tripartite MDR efﬂux pump.
The mutation altered the substrate speciﬁcity of the pump by affecting the drug-binding pocket,
resulting in increased accumulation of ciproﬂoxacin, a key drug in the therapy of the patient,
while decreasing accumulation of other drugs [60]. Evidence for how within-host evolution
results in altered substrate speciﬁcities has the potential to inform effective treatment
combinations in future complicated infections.
Within-Host Evolution in Experimental Infections
The observation of within-host evolution in clinical infections is limited by the lack of routine
whole-genome sequencing of clinical isolates, and the rarity of chronic infections. Clinical
investigations are also, by necessity, restricted to observing evolution during the course of an
infection within the conﬁnes of clinical management, and carefully controlled experimentation is
not possible, complicating interpretation. An alternative is the employment of animal models of
Box 3. Within-Host Evolution during a Chronic Bacteraemia Infection
In a rare clinical case, a patient with IL-12/23 b1 receptor deﬁciency presented with recurring bacteraemia spanning 15 years, despite repeated antibiotic and
interferon(IF)-g treatments [61] (Figure I). The whole-genome sequence revealed diversiﬁcation with a molecular clock rate of 1  105 SNPs per site per year, around
50-fold higher than that observed in Salmonella epidemics over similar time periods [1,52,53]. Rapid mutation was due to deletion within the mutS gene, conferring a
hypermutator phenotype. All the patient isolates shared a set of mutations in common, consistent with early selection of mutations affecting phenotypes that
conferred a strong advantage over progenitor variants. Later in infection, evolution resulted in multiple lineages deﬁned by mutations present in one or a subset of
isolates, likely to not confer such a robust advantage. Such early emergence of beneﬁcial mutations and the rapid reduction in the relative advantage of subsequent
mutations was also observed in experimental evolution of E. coli during adaptation in vitro [102]. Purifying selection dominated overall, as dN/dS <1, suggesting that
many mutations had no selective advantage and were therefore lost from the population. However, dN/dS was greater than that observed for S. Enteritidis
populations evolving with a normal lifestyle, suggesting that diversifying selection associated with adaptation was evident. A relatively low dN/dS is typical within
evolving populations of S. Typhimurium, including during epidemics and outbreaks over evolutionary time scales, similar to that observed in the patient [1]. A notable
exception is in S. Typhi populations, that, like the S. Enteritidis in the patient, have an elevated dN/dS, approaching unity [103], consistent with selection for some
nonsynonymous mutations as they confer an advantage. That functional changes were under the inﬂuence of diversifying selection in the isolates from the patient was
also suggested by the observation that proteins were more likely to contain substitutions in highly conserved functional domains, compared to S. Enteritidis evolving
through gastroenteritis infections [61,98]. Many of these mutations are likely to be loss-of-function mutations in proteins that were no longer required for the infection,
a characteristic of in-host adaptation of Salmonella serovars such as S. Typhi and S. Gallinarum [31,98]. Loss-of-function mutations were also evident in the presence
of pseudogenes, similar in number and their functional classiﬁcation to that reported for S. Typhi, and consistent with observed attenuation of virulence on challenge
of subsequent hosts [14,31].
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infection, a wide range of which are well characterized for Salmonella [49,64], in which selection
pressure can be ﬁnely controlled. In particular, the impact of HGT on transfer of antibiotic
resistance, or virulence genes, has been studied using the murine infection model [33,65].
HGT within the Host
HGT is mediated by a number of mechanisms including conjugation, transformation, and
phage-mediated transduction or lysogeny [66] (Box 2). The potential for HGT during intestinal
infections is considerable due to the complex and numerous intestinal microbiota [67,68].
Conjugation is the dominant mechanism, used by ICEs and plasmids, but likely plays an
important role in transfer of other mobile genetic elements (MGEs), such as transposons.
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Figure I. Within-Host Evolution of S. Enteritidis during Clinical Infection. Summary of disease progression and within-host evolution in a patient with
interleukin-12/23 (IL 12/23) b1 receptor deﬁciency. A maximum likelihood tree based on core genome sequence variation of 11 sequential strains isolated from the
blood of the patient over a 10-year period, and a typical S. Enteritidis PT4 strain (centre), as reported previously [61]. Numerals and colored edges in the phylogenetic
tree indicate the number of pseudogenes that were introduced [61].
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Antibiotic-resistance genes are present on the chromosome or on plasmids in Salmonella,
often associated with MGEs such as composite transposons or ICEs [14,37,69–72]. A number
of factors impact the frequency of plasmid transfer. In Escherichia coli, conjugation was found
to predominantly occur in the mucus layer, probably due to the stabilising properties of this
matrix [73]. Proximity of donor and recipient is also an important factor for conjugation, and the
density of cells plays an important role in the frequency of transfer [74]. Inﬂammation induced by
Salmonella during colitis results in a proteobacterial bloom, including outgrowth of the patho-
gen [5,75], thereby bringing related species into close proximity. These conditions enhanced
the transfer of plasmid pII between Salmonella and commensal E. coli [33]. Many Salmonella
serotypes encode an IncF plasmid called pSLT, or the virulence plasmid, due to the presence of
spv genes required for systemic infections in mice. Transfer of pSLT occurs at low frequency
during in vitro culture [76] but increases markedly in the mouse intestine, in response to high
osmolarity and microaerobiosis [65,77]. Furthermore, transfer is considerably higher in the
intestine compared to systemic sites of infection, highlighting the importance of the intestinal
phase of infection for conjugative transfer. Transfer of plasmids between Salmonella strains can
occur directly, but the microbiota may also play an important role as an intermediary. A large
plasmid from S. Infantis, conferring the MDR phenotype, was transferred to E. coli and even to
Gram-positive species, such as Lactobacillus reuteri, in experimental infections of mice. The
plasmid was then further transferred to a second Salmonella serovar, S. Typhimurium, dem-
onstrating a complex network of HGT in the intestine [78].
Stress imposed on Salmonella and the microbiota by antibiotics, bile, and host inﬂammation
boosts HGT, likely an adaptation of MGEs to maximise their replication [79]. This characteristic
of MGEs contributes signiﬁcantly to the spread of genetically linked antibiotic-resistance genes
and virulence genes. In addition to increasing the density of Salmonella and other proteobac-
teria in the intestine, inﬂammation induces the SOS stress response in Salmonella through the
action of hypochlorite, reactive oxygen and reactive nitrogen species from transmigrated
luminal granulocytes. The response has long been known to activate prophage, temperate
phage commonly found inserted in the genome of bacteria [80], and more recently, ICEs [81].
Inﬂammation in the intestinal lumen is therefore likely to result in an increase in the transfer of
DNA between the microbiota and pathogens by generalised transduction, although this has not
been reported to date. However, prophage in the chromosome of Salmonella commonly
encodes virulence factors, including superoxide dismutase SodCI, and a number of type III
secretion system effector proteins [82]. One such phage, SopEF, encodes the T3SS effector
protein, SopE, that boosts host cell invasion and inﬂammation [7,83–85]. Transfer of SopEF
between the chromosome of two cocolonizing S. Typhimurium strains, by a process called
lysogenic conversion, was considerably increased in the inﬂamed intestine [79]. Lysogenic
conversion by SopEF has been associated with epidemic clones of S. Typhimurium in the past
[86], and a current pandemic MDR clone of S. 4,[5],12:i:– (monophasic S. Typhimurium) has
acquired the sopE gene on multiple occasions on a novel phage termed mtmVF [69].
Acquisition was accompanied by further clonal expansion, and within a 5-year period the
proportion of strains encoding sopE increased from around 0% to 40% [69]. Lysogenic
conversion by a temperate phage during clonal expansion of the MDR S. 4,[5],12:i:– clone
highlights the potential for microevolution over very short periods of time that changes the
nature and potentially the course of an epidemic.
Concluding Remarks and Future Perspective
The revolution in recombinant DNA technology in the 20th century led to fruitful decades of
research that employed molecular Koch’s postulates to study the molecular basis of bacterial
pathogenicity [87]. With the advent of whole-genome sequencing technologies, determination
Outstanding Questions
Does S. Typhi evolve during chronic
carriage in the gall bladder?
How does S. Typhi avoid loss of viru-
lence and transmissibility during
chronic carriage in the gall bladder?
What is the extent of HGT between
coinfecting Salmonella and with the
microbiota in the intestine during Sal-
monella gastroenteritis?
What are the barriers that limit intra-
species and intraphylum HGT in the
intestine?
Does transient hypermutation contrib-
ute to the rapid emergence of new
Salmonella pathovars?
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of variation in whole-genome sequences that accompanies host adaptation of pathovariants,
or within-host evolution under selection, has the potential to harness the naturally occurring
variation and provides a complementary approach that not only provides insight into the
mechanisms of pathogenesis, but also the emergence of new pathogens (see Outstanding
Questions). Genome degradation associated with the evolution of host-adapted pathovars of
Salmonella has revealed important metabolic activities speciﬁcally required for the intestinal
phase of infection, but dispensable for disseminated disease. Direct observations of within-host
evolution during chronic infections of individuals conﬁrmed convergent pathways to host
adaptation. Routine whole-genome sequencing of bacterial pathogens is being introduced
in a number of countries for epidemiological surveillance. Its application in chronic and
complicated Salmonella infections is a promising approach to provide data relevant to clinical
management and insight into treatment failure.
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